TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SANGAIR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

SANGAIR

ST13

US500000079360701

Class

10

Filing

79360701

Registration

7369675

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

11/17/2024

Classification

Registered

Trademark type

Word

Nice classes

10

Filing date

10/13/2022

Registration date

04/30/2024

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/30/2024

Last transaction

04/30/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

64

Owner location

SE

Examiner

BLAZICH,JOAN MICHELE

Law office

N40

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Sangair AB

Representatives

Jason Sanders Sanders IP Law

Technical classification

Nice Classes

Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

Medical apparatus and devices, in particular for the treatment of sepsis; medical apparatus and devices for counteracting the effects of viruses, bacteria and pathogens in the blood and blood components by contacting blood with ozone gas; medical devices for the treatment of blood infections and sepsis by using active oxygen; oxygenators for medical use, namely, for treating blood infections and sepsis; ozonisers being ozonators for treating blood infections and sepsis for medical use; disposable medical devices for treating blood

Publications

History of USPTO decisions and trademark events.

25 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

11/17/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

10/27/2024

FIMP

FINAL DISPOSITION PROCESSED

10/27/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

07/30/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/30/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

04/30/2024

GPNX

NOTIFICATION PROCESSED BY IB

02/14/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/13/2024

PUBO

PUBLISHED FOR OPPOSITION

02/13/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/24/2024

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

01/24/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/24/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/05/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/03/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/03/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/03/2024

RFNT

REFUSAL PROCESSED BY IB

09/13/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

08/24/2023

RFRR

REFUSAL PROCESSED BY MPU

08/24/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

08/02/2023

CNRT

NON-FINAL ACTION WRITTEN

08/01/2023

DOCK

ASSIGNED TO EXAMINER

07/28/2023

MAFR

APPLICATION FILING RECEIPT MAILED

01/24/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/20/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

01/19/2023

Continuous trademark protection

Get notified about every new filing that threatens SANGAIR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.